The efficacy of acupuncture treatment for fibromyalgia syndrome: a systematic review and meta-analysis

Fibromyalgia is a complex medical condition that affects millions of people worldwide, characterized by widespread, chronic muscle pain that persists for more than three months. This syndrome goes far beyond pain, being accompanied by a series of debilitating symptoms such as intense fatigue, sleep disturbances, anxiety, and depression. Considered the third most prevalent musculoskeletal condition, fibromyalgia has a higher incidence between ages 50 and 60 and generates significant impact on patients' quality of life. People with fibromyalgia require almost twice as many medical visits per year compared with healthy individuals, and their total health care costs are estimated to be three times higher than those of the general population.

Current pharmacologic treatment, based mainly on medications such as pregabalin, duloxetine, and tramadol, has important limitations, with only 30% to 50% of patients responding adequately to treatment, in addition to frequent side effects such as dizziness, weight gain, nausea, and sexual dysfunction.

This study aimed to investigate whether acupuncture has effective therapeutic effects in the treatment of patients with fibromyalgia. To do so, the researchers performed a systematic review and meta-analysis, a rigorous form of analysis that combines data from multiple studies to obtain more robust conclusions. The methodology involved searching eight scientific databases to identify randomized controlled trials that evaluated acupuncture interventions in patients with fibromyalgia. The researchers used specific tools to assess the methodologic quality of the included studies and applied statistical tests to detect heterogeneity among studies.

Primary outcomes analyzed were the visual analog scale of pain, the Fibromyalgia Impact Questionnaire, and the number of tender points, in addition to secondary outcomes including depression, sleep quality, and fatigue. The intervention group received acupuncture, while control groups received conventional medications for pain, sham acupuncture, or no intervention.

The research results were promising and statistically significant in several important areas. Seventeen clinical trials involving 1,066 patients were included, and the meta-analysis demonstrated that the group receiving acupuncture had significantly lower pain scores on the visual analog scale, with a standardized mean difference of -0.77. The Fibromyalgia Impact Questionnaire, which assesses how the condition affects patients' daily lives, also showed significant improvement in the acupuncture group, with a reduction of -0.98 points. The number of tender points decreased substantially, with a reduction of -1.36 points.

In addition, acupuncture demonstrated efficacy in improving depression, with a reduction of -0.78 points, and fatigue, with a decrease of -0.51 points. However, no significant improvements in sleep quality were observed. Subgroup analyses revealed that treatment duration may influence outcomes, with benefits observed in periods of 2 to 4 weeks, 5 to 6 weeks, and 8 to 12 weeks for different symptoms.

The clinical implications of these findings are considerable for both patients and health care professionals. Acupuncture emerges as a safe and effective therapeutic option for the treatment of fibromyalgia, offering an alternative or complement to traditional pharmacologic treatment. The results suggest that acupuncture can be incorporated into clinical guidelines as a complementary or alternative approach to medications, especially considering its limited side effects compared with pharmacologic treatments. For clinical practice, the researchers recommend adjusting treatment duration based on disease severity: mild cases may benefit from 2 to 4 weeks of treatment, while moderate to severe cases should extend therapy to 8 to 12 weeks to maintain efficacy.

Acupuncture point selection is also important, with commonly used points including BL-18, BL-20, Ashi points, SP-6, and LI-4, in addition to specific points based on presenting symptoms, such as GV-20 for depression and ST-36 for fatigue. The included studies reported only mild and transient local adverse reactions, such as discomfort, pain, bruising, and some systemic reactions such as dizziness and nausea, which were well tolerated by patients.

This study has some important limitations that should be considered when interpreting the results. Some of the included articles did not use adequate blinding methods, which may have influenced the results. The sample size for some indicators was relatively small, possibly affected by small-sample effects. High heterogeneity was observed across some outcomes, and some included studies had unclear or high risk of bias, which may have introduced some degree of bias into the results.

There is also potential publication bias due to the concentration of single-center Chinese studies. The researchers emphasize that these findings should be verified in future higher-quality studies with larger samples. Despite the limitations, this work provides evidence-based support for the treatment of fibromyalgia with acupuncture and may serve as a reference for subsequent clinical studies, representing an important step in the scientific validation of integrative therapies for this complex and debilitating condition.